Aging & Elder Health Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging & Elder Health Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alexion Pharmaceuticals, Inc.
Ruedi E. Waeger appointed to board of directors at pharmaceutical firm
April 10th, 2005
Alexion Pharmaceuticals, Inc., (ALXN) announced that Ruedi E. Waeger, PhD, has been appointed to the company's board of directors. The Board, including Waeger, is composed of eight members. "We are very pleased to add Ruedi to our Board. His experience in the development, manufacture and marketing of therapeutic products will be extremely beneficial as we continue to move forward with our on-going, pivotal phase III programs with eculizumab and pexelizumab," said Leonard Bell, MD, CEO of Alexion. "In particular, we expect that Ruedi's marketing and management expertise in the U.S. and Europe will be highly valuable as we develop and implement our...
Source: Aging & Elder Health Week (2005-04-10)
|
